Noninvasive prenatal testing (NIPT) is now clinically available for screening fetal
subchromosomal copy number variations (CNVs).
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Presence of fetal DNA in maternal plasma and serum.Lancet. 1997; 350: 485-487
- Sequencing of circulating cell-free DNA during pregnancy.N Engl J Med. 2018; 379: 464-473
- Current use of noninvasive prenatal testing in Europe, Australia and the USA: a graphical presentation.Acta Obstet Gynecol Scand. 2020; 99: 722-730
- Outcome of publicly funded nationwide first-tier noninvasive prenatal screening.Genet Med. 2021; 23: 1137-1142
- Chromosomal microarray versus karyotyping for prenatal diagnosis.N Engl J Med. 2012; 367: 2175-2184
- Low-pass genome sequencing versus chromosomal microarray analysis: implementation in prenatal diagnosis.Genet Med. 2020; 22: 500-510
- Diagnosis and clinical management of duplications and deletions.Fertil Steril. 2017; 107: 12-18
- Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics.Genet Med. 2016; 18: 1056-1065
- Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes.Genet Med. 2019; 21: 1998-2006
- TRIDENT-2: national implementation of genome-wide non-invasive prenatal testing as a first-tier screening test in the Netherlands.Am J Hum Genet. 2019; 105: 1091-1101
- Noninvasive prenatal diagnosis of fetal trisomy 21 by allelic ratio analysis using targeted massively parallel sequencing of maternal plasma DNA.PLoS One. 2012; 7: e38154
- Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma.Proc Natl Acad Sci U S A. 2008; 105: 20458-20463
- Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing.Prenat Diagn. 2015; 35: 999-1004
- Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes.Am J Obstet Gynecol. 2015; 212: 332 e1-9
- Clinical experience with a single-nucleotide polymorphism-based non-invasive prenatal test for five clinically significant microdeletions.Clin Genet. 2018; 93: 293-300
- Clinical validation of a noninvasive prenatal test for genomewide detection of fetal copy number variants.Am J Obstet Gynecol. 2016; 215: 227.e1-227.e16
- Detection of fetal copy number variants by non-invasive prenatal testing for common aneuploidies.Ultrasound Obstet Gynecol. 2016; 47: 53-57
- Performance evaluation of NIPT in detection of chromosomal copy number variants using low-coverage whole-genome sequencing of plasma DNA.PLoS One. 2016; 11: e0159233
- Genome sequencing explores complexity of chromosomal abnormalities in recurrent miscarriage.Am J Hum Genet. 2019; 105: 1102-1111
- A cytogeneticist’s perspective on genomic microarrays.Hum Reprod Update. 2004; 10: 221-226
- Fluorescence in situ hybridization (FISH): history, limitations and what to expect from micro-scale FISH?.Micro Nano Eng. 2018; 1: 15-24
- Are all chromosome microarrays the same? What clinicians need to know.Prenat Diagn. 2019; 39: 157-164
- Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.Am J Hum Genet. 2010; 86: 749-764
- Low-pass whole-genome sequencing in clinical cytogenetics: a validated approach.Genet Med. 2016; 18: 940-948
- Screening for fetal chromosomal abnormalities: ACOG Practice Bulletin, Number 226.Obstet Gynecol. 2020; 136: e48-e69
- Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening.Eur J Hum Genet. 2015; 23: 1438-1450
- Detection of fetal subchromosomal abnormalities by sequencing circulating cell-free DNA from maternal plasma.Clin Chem. 2015; 61: 608-616
- The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies.Prenat Diagn. 2013; 33: 667-674
- Noninvasive detection of fetal subchromosomal abnormalities by semiconductor sequencing of maternal plasma DNA.Proc Natl Acad Sci U S A. 2015; 112: 14670-14675
- High-throughput fetal fraction amplification increases analytical performance of noninvasive prenatal screening.Genet Med. 2021; 23: 443-450
- Enrichment of the fetal fraction in non-invasive prenatal screening reduces maternal background interference.Sci Rep. 2018; 8: 17675
- An enrichment method to increase cell-free fetal DNA fraction and significantly reduce false negatives and test failures for non-invasive prenatal screening: a feasibility study.J Transl Med. 2019; 17: 124
- A method for improving the accuracy of non-invasive prenatal screening by cell-free foetal DNA size selection.Br J Biomed Sci. 2018; 75: 133-138
- Evaluation and optimisation of preparative semi-automated electrophoresis systems for Illumina library preparation.Electrophoresis. 2012; 33: 3521-3528
- Enrichment of fetal and maternal long cell-free DNA fragments from maternal plasma following DNA repair.Prenat Diagn. 2019; 39: 88-99
- Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus.Sci Transl Med. 2010; 2: 61ra91
- Analysis of the size distributions of fetal and maternal cell-free DNA by paired-end sequencing.Clin Chem. 2010; 56: 1279-1286
- High-resolution DNA size enrichment using a magnetic nano-platform and application in non-invasive prenatal testing.Analyst. 2020; 145: 5733-5739
- Sequencing shorter cfDNA fragments improves the fetal DNA fraction in noninvasive prenatal testing.Am J Obstet Gynecol. 2019; 221: 345.e1-345.e11
- Sequencing of short cfDNA fragments in NIPT improves fetal fraction with higher maternal BMI and early gestational age.Am J Transl Res. 2019; 11: 4450-4459
- Improved protocols for the Illumina genome analyzer sequencing system.Curr Protoc Hum Genet. 2009; (Chapter 18:Unit 18 2)
- Limited clinical utility of non-invasive prenatal testing for subchromosomal abnormalities.Am J Hum Genet. 2016; 98: 34-44
- Probabilistic method for detecting copy number variation in a fetal genome using maternal plasma sequencing.Bioinformatics. 2014; 30: i212-i218
- Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma.Am J Hum Genet. 2013; 92: 167-176
- Non-invasive prenatal testing (NIPT) by low coverage genomic sequencing: detection limits of screened chromosomal microdeletions.PLoS One. 2020; 15: e0238245
- Noninvasive prenatal diagnosis of common aneuploidies by semiconductor sequencing.Proc Natl Acad Sci U S A. 2014; 111: 7415-7420
- When genotype is not predictive of phenotype: implications for genetic counseling based on 21,594 chromosomal microarray analysis examinations.Genet Med. 2018; 20: 128-131
- Estimates of penetrance for recurrent pathogenic copy-number variations.Genet Med. 2013; 15: 478-481
- Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 8141 single pregnancies.Hum Genomics. 2019; 13: 14
- Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen).Genet Med. 2020; 22: 245-257
- Phenotypic heterogeneity of genomic disorders and rare copy-number variants.N Engl J Med. 2012; 367: 1321-1331
- Recommended pre-test counseling points for noninvasive prenatal testing using cell-free DNA: a 2015 perspective.Prenat Diagn. 2015; 35: 968-971
- 22q11.2 deletion syndrome.in: Adam M.P. Ardinger H.H. Pagon R.A. GeneReviews® [Internet]. University of Washington, Seattle, Seattle (WA)2020: 1993-2021 (Available at:)
- Prader-Willi syndrome.in: Adam M.P. Ardinger H.H. Pagon R.A. GeneReviews® [Internet]. University of Washington, Seattle, Seattle (WA)1998: 1993-2021 (Available at:)
- Angelman syndrome.in: Adam M.P. Ardinger H.H. Pagon R.A. GeneReviews® [Internet]. University of Washington, Seattle, Seattle (WA)1998 (1993-2021. Available at:)
- Cri du chat syndrome.Orphanet J Rare Dis. 2006; 1: 33
- DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources.Am J Hum Genet. 2009; 84: 524-533
- 1p36 deletion syndrome: an update.Appl Clin Genet. 2015; 8: 189-200
- Wolf-Hirschhorn syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY.([Updated 2015 Aug 20])in: Adam M.P. Ardinger H.H. Pagon R.A. GeneReviews® [Internet]. University of Washington, Seattle, Seattle (WA)2002 (1993-2021. Available at:)
- Wolf-Hirschhorn syndrome: a review and update.Am J Med Genet C Semin Med Genet. 2015; 169: 216-223
- Jacobsen syndrome.Orphanet J Rare Dis. 2009; 4: 9
- Trichorhinophalangeal syndrome.in: Adam M.P. Ardinger H.H. Pagon R.A. GeneReviews® [Internet]. University of Washington, Seattle, Seattle (WA)2017: 1993-2021 (Available at:)
Article info
Footnotes
This article originally appeared in Advances in Molecular Pathology, Volume 4, Issue 1, November 2021.
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
